Discuss This Drug

bezlotoxumab

CHEBI:CHEBI_756332

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

generic_name
bezlotoxumab
listing_expiration_date
20251231
dosage_form
INJECTION, SOLUTION
active_ingredient_strength
25 mg/mL
product_type
DRUG FOR FURTHER PROCESSING
marketing_category
DRUG FOR FURTHER PROCESSING
labeler_name
MSD Ireland (Carlow)
active_ingredient_name
BEZLOTOXUMAB
product_ndc
69497-0002
marketing_start_date
20161023
spl_id
427ad02c-7495-4f8d-b3de-3ccc043fc37f
package_ndc
69497-0002-0
package_description
63 VIAL, SINGLE-DOSE in 1 TRAY (69497-0002-0) / 40 mL in 1 VIAL, SINGLE-DOSE
package_marketing_start_date
23-OCT-16
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class